Please Wait
Applying Filters...
menu
    • menu
    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.

    Virtual Booth

    Contact Supplier

    AbbVie Contract Manufacturing partners globally to develop, scale, and manufacture pharmaceutical products successfully.

    Virtual Booth

    Contact Supplier

    Topscience Biotech is a one-stop supplier of sodium hyaluronate//drug manufacturing license, CEP, GMP, DMF, and Form 41 certifications.

    Virtual Booth

    Contact Supplier

    Zach System is committed to providing Highly Customized Solutions for all your Development Programs.

    Virtual Booth

    Contact Supplier

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    An Enquiry

    Menu

    Tagraxofusp

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Menarini Group Presents New Oncology Data at ASCO 2026
    Menarini Group Presents New Oncology Data at ASCO 2026

    26 May 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/menarini-group-announces-new-data-at-the-american-society-of-clinical-oncology-asco-2026-annual-meeting-302781074.html

    PR NEWSWIRE
    26 May 2026
    Share Share
    Menarini Group Unveils Elzonris Data at ASH Annual Meeting
    Menarini Group Unveils Elzonris Data at ASH Annual Meeting

    24 Nov 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/menarini-group-announces-new-data-on-elzonris-tagraxofusp-erzs-to-be-presented-at-the-67th-american-society-of-hematology-annual-meeting-and-exposition-302624638.html

    PR NEWSWIRE
    24 Nov 2025
    Share Share
    Menarini Group Announces New Data on ORSERDU® (elacestrant) at Symposium
    Menarini Group Announces New Data on ORSERDU® (elacestrant) at Symposium

    21 Nov 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/menarini-group-announces-new-data-on-orserdu-elacestrant-at-the-2023-san-antonio-breast-cancer-symposium-and-on-elzonris-tagraxofusp-erzs-at-the-65th-american-society-of-hematology-annual-meeting-and-exposition-301994634.html

    PR NEWSWIRE
    21 Nov 2023
    Share Share
    Menarini Group Announces New Data on ORSERDU
    Menarini Group Announces New Data on ORSERDU

    20 Nov 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20231120740422/en

    BUSINESSWIRE
    20 Nov 2023
    Share Share
    Fox Chase Social Worker Anjali Albanese to Receive 2023 Compassionate Care Award
    Fox Chase Social Worker Anjali Albanese to Receive 2023 Compassionate Care Award

    31 Aug 2023

    // ONCLIVE

    https://www.onclive.com/view/fox-chase-social-worker-anjali-albanese-to-receive-2023-compassionate-care-award-from-sarcoma-foundation-of-america

    ONCLIVE
    31 Aug 2023
    Share Share
    The Menarini Group Announces ELZONRIS Designated as an Orphan Drug for BPDCN
    The Menarini Group Announces ELZONRIS Designated as an Orphan Drug for BPDCN

    30 Aug 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20230830257431/en

    BUSINESSWIRE
    30 Aug 2023
    Share Share
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.